amitriptyline has been researched along with Brittle Bone Disease in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez López, JC | 1 |
| González De Zárate, J | 1 |
| Herrero Gento, E | 1 |
1 other study available for amitriptyline and Brittle Bone Disease
| Article | Year |
|---|---|
[Treatment of pain in a case of osteogenesis imperfecta type III].
Topics: Adolescent; Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Drug Therapy, Combination; Female; | 2002 |